LFSC

F/m Emerald Life Sciences Innovation ETF

Current Price
$45.14
Market Cap
$125.06 M
RETURN (12M)
54.96%
RETURN (5Y)
-
DY
0.00%
Price

LFSC PRICE

Select period
Select period
F/m Emerald Life Sciences Innovation ETF
If you had invested
If you had invested
exposure
years ago
7 days
30 days
6 months
YTD
1 year
5 years
10 years
15 years
ago, you would now have *
ago, you would now have:
*
*This calculation reflects price variation only.

Return on Investment LFSC

1 month
3 months
1 year
2 years
5 years
10 years
return
1 month
-6.02%
3 months
6.31%
1 year
54.96%
2 years
0.00%
5 years
0.00%
10 years
0.00%
Price

Stock vs Indice Comparison Tool

If you had invested
If you had invested
years ago
2 years
5 years
10 years
ago, you would now have *
ago, you would now have:
*
*This calculation reflects price variation only.
Composição

ETF COMPOSITION LFSC

Company name Ticker Asset type Sector Market cap % in ETF
TVTX Stock Healthcare US$ 6.27 B 8,71%
CORT Stock Healthcare US$ 12.07 B 6,72%
Spyre Therapeutics Inc.
SYRE Stock Healthcare US$ 7.73 B 6,70%
LIVN Stock Healthcare US$ 4.46 B 6,61%
Cogent Biosciences Inc
UMRX Stock Healthcare US$ 73.23 M 6,48%
MIRM Stock Healthcare US$ 6.15 B 4,32%
BillionToOne, Inc. Class A Common Stock
BLLN Stock Healthcare US$ 4.69 B 3,86%
GH Stock Healthcare US$ 21.66 B 3,81%
CYTK Stock Healthcare US$ 10.28 B 3,50%
UTHR Stock Healthcare US$ 20.91 B 3,27%
AXSM Stock Healthcare US$ 10.91 B 3,05%
NKTR Stock Healthcare US$ 2.53 B 2,97%
TMDX Stock Healthcare US$ 3.12 B 2,91%
SVRA Stock Healthcare US$ 1.10 B 2,87%
Veradermics, Incorporated
MANE Stock Healthcare US$ 4.08 B 2,87%
ICUI Stock Healthcare US$ 4.19 B 2,77%
DNTH Stock Healthcare US$ 5.91 B 2,70%
TRVI Stock Healthcare US$ 2.46 B 2,59%
VRDN Stock Healthcare US$ 2.60 B 2,53%
Palvella Therapeutics, Inc
PVLA Stock Healthcare US$ 2.24 B 2,15%
TWST Stock Healthcare US$ 8.21 B 2,03%
CRVS Stock Healthcare US$ 1.23 B 1,90%
CeriBell, Inc
CBLL Stock Healthcare US$ 948.71 M 1,73%
HNGE Stock Healthcare US$ 7.32 B 1,33%
NEO Stock Healthcare US$ 2.23 B 1,21%
WAY Stock Healthcare US$ 4.81 B 1,18%
Aveanna Healthcare Holdings Inc
AVAH Stock Healthcare US$ 2.98 B 1,16%
ATEC Stock Healthcare US$ 1.46 B 1,11%
GMED Stock Healthcare US$ 10.51 B 1,08%
PRAX Stock Healthcare US$ 9.82 B 0,98%
RDNT Stock Healthcare US$ 5.87 B 0,92%
Lumexa Imaging Holdings, Inc. Common Stock
LMRI Stock Healthcare US$ 1.14 B 0,91%
Korro Bio, Inc.
KRRO Stock Healthcare US$ 180.24 M 0,64%
INSM Stock Healthcare US$ 27.58 B 0,60%
Definium Therapeutics, Inc.
DFTX Stock Healthcare US$ 5.81 B 0,57%
REPL Stock Healthcare US$ 1.42 B 0,55%
Alamar Biosciences, Inc. Common Stock
ALMR Stock Healthcare US$ 2.12 B 0,24%

ABOUT

F/m Emerald Life Sciences Innovation ETF

Average Investor10 user rating

4.0 (0 people)

Frequently Asked Questions

What is the price of LFSC today?

The current price of LFSC is $45.14. You can track the real-time price chart, review historical performance, and access detailed information about this ETF on the platform.

Is LFSC a good investment?

LFSC is currently trading at $45.14, with a market capitalization of approximately $125.064.043,00. Over the past year, the ETF has delivered a 54.96% return, based on share price performance.

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

How can I buy shares of LFSC?

You can invest in LFSC through a brokerage account that provides access to the exchange where it is listed. After opening and funding your account, search for the ticker symbol LFSC, select the number of shares you wish to purchase, and place your order.

In certain markets, similar exposure may also be available through locally listed products that track the same index.

How much would 100 shares of LFSC be worth today?

Over the past month, LFSC has returned -6.02%, and 54.96% over the past year.

If you were to purchase 100 shares of LFSC at the current price of $45.14, your total investment would be $4,514.00.

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.